Recombinant mite allergens: New technologies for the management of patients with asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 4, 1997, Pages 374-379

  Chapman, M D ^a,b   Smith, A M ^a   Vailes, L D ^a   Arruda, L K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

allergens; asthma; biotechnology; house dust mites; immunotherapy

Indexed keywords

ALLERGEN; CHIMERIC ANTIBODY; COMPLEMENTARY DNA; DNA VACCINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 12; MONOCLONAL ANTIBODY; OVALBUMIN; RECOMBINANT PROTEIN;

ALLERGY; ASTHMA; BIOTECHNOLOGY; CONFERENCE PAPER; DERMATOPHAGOIDES PTERONYSSINUS; DIAGNOSTIC TEST; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INTRADERMAL DRUG ADMINISTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SKIN TEST;

EID: 0030968754     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb01014.x     Document Type: Conference Paper

References (34)

1. Thomas WR. Molecular analysis of house dust mite allergens. In: Walker MR, Roberts AM, editors. Molecular analysis of mediated hypersensitivity and strategies for immunologic intervention. Chichester: Wiley, 1997: in press.
2. Platts-Mills TAE, Thomas WR, Aalberse RC, Vervloet D, Chapman MD. Report of the Third International Workshop on Indoor Allergens and Asthma. J Allergy Clin Immunol 1997; in press.
3. van Neerven RJ, Ebner C, Yssel H, Kapsenburg ML, Lamb JR. T cell responses to allergens: epitope-specificity and clinical relevance. Immunol Today 1996;17:526-32.
4. Topham C, Srinivasan N, Thorpe C, Overington J, Kalsheker N. Comparative modelling of major house dust mite allergen Der p 1: structure validation using an extended environmental amino acid propensity table. Protein Eng 1994;7:869-94.
5. Tovey ER, Baldo BA. Comparison by electroblotting of IgE-binding components in extracts of house dust mite bodies and spent mite culture. J Allergy Clin Immunol 1987;79:93-102.
6. Shen HD, Chua KY, Lin KL, Hsieh KH, Thomas WR. Molecular cloning of a house dust mite allergen with common antibody binding specificities with multiple components in mite extracts. Clin Exp Allergy 1993;23:934-40.
7. King C, Simpson RJ, Moritz RT, Thompson PJ, Stewart GA. Isolation and characterization of a novel collagenolytic serine protease, Der p 9, from the house dust mite, Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1996;98:739-47.
8. O'Neill GM, Donovan GR, Baldo BA. Cloning and characterization of a major allergen of the house dust mite, Dermatophagoides pteronyssinus, homologous with glutathione S-transferase. Biocimica Biophys 1994;1219:521-8.
9. Tovey ER, Johnson MC, Roche AL, Cobon GS, Baldo BA. Cloning and sequencing of a cDNA expressing a recombinant house dust mite protein that binds human IgE and corresponds to an important low molecular weight allergen [published erratum appears in J Exp Med 1990;171(4):1387]. J Exp Med 1989;170:1457-62.
10. Lin KL, Hsieh KS, Thomas WR, Chiang BL, Chua KY. Characterization of Der p V allergen, cDNA analysis, IgE mediated reactivity to the recombinant protein. J Allergy Clin Immunol 1994;94:989-96.
11. Robinson C, Kalsheker NA, Srinivasan N, et al. On the potential significance of the enzymatic activity of mite allergens to immunogenicity. Clues to structure and function revealed by molecular characterization. Clin Exp Allergy 1997;27:10-21.
12. Thomas WR, Chua K-Y. The major mite allergen Der p 2 - a secretion of the male mite reproductive tract? Clin Exp Allergy 1995;25:666-9.
13. Schulz O, Laing P, Sewell HE, Shakib F. Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol 1995;25:3191-4.
14. Hewitt CRA, Brown AP, Hart BJ, Pritchard DI. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995;182:1537-44.
15. Kent NA, Hill MR, Holland PWH, Han BJ. Molecular characterization of group I allergen Eur m I from house dust mite Euroglyphus maynei. Int Arch Allergy Appl Immunol 1992;99:150-2.
16. Varela J, Ventas P, Carreira JA, Barbas G, Gimenez-Gallego, Polo F. Primary structure of Lep d 1, the main Lepidoglyphus destructor allergen. Eur J Biochem 1994; 225:93-7.
17. Arruda LK, Chapman MD. A review of recent immunochemical studies of Blomia tropicalis and Euroglyphus maynei allergens. Exp Appl Acarol 1992;16:129-40.
18. Arruda LK, Vailes LD, Platts-Mills TAE, et al. Sensitization to Blomia tropicalis in patients with asthma and identification of allergen Blo t 5. Am J Respir Crit Care Med 1997;155:343-50.
19. Caraballo L, Avjioglu A, Marrugo J, Puerta L, Marsh D. Cloning and expression of complementary DNA coding for an allergen with common antibody-binding specificities with three allergens of the house dust mite Blomia tropicalis. J Allergy Clin Immunol 1996;98:573-9.
20. Puerta L, Caraballo L, Fernandez-Caldas E, et al. Nucleotide sequence of a cDNA coding for a Blomia tropicalis allergen. J Allergy Clin Immunol 1997; in press.
21. Smith A, Green R, Custovic A, Woodcock A, Arruda K, Chapman MD. In vivo cross-reactivity between IgG Ab to Blomia and Dermatophagoides spp. and to the recombinant group 5 allergens among mite allergic patients living in the UK [Abstract]. J Allergy Clin Immunol 1996;97: 420.
22. Arruda LK, Rizzo MC, Naspitz CK, Vailes LD, Chapman MD. Skin test reactivity to recombinant group 5 allergens in mite allergic children living in São Paulo, Brazil. J Allergy Clin Immunol 1997; in press.
23. Chapman MD, Vailes L, Bavbek S, et al. Multi-center study of the biologic activity of recombinant group 5 mite allergens. J Allergy Clin Immunol 1997; in press.
24. Schuurman J, Perdok GJ, Lourens TE, Parren PWHI, Chapman MD, Aalberse RC. The production of a mouse/ human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen specific IgE. J Allergy Clin Immunol 1997; in press.
25. Elderfield A, Schuurman J, Aalberse RC, Smith A, Woodcock A, Chapman MD. Absolute quantitation of mite specific IgE antibody levels using a chimeric mouse Fab/ human Fc epsilon antibody to Der p 2 [Abstract]. J Allergy Clin Immunol 1996;97:301.
26. Chapman MD, Williams L, Chandler J. ̃Drawing the linẽ - rapid diagnostic tests (RDT) for the detection of dust mite, cat and cockroach allergens [Abstract]. J Allergy Clin Immunol 1996;97:302.
27. Use of standardized allergen extracts. Position Statement. American Academy of Allergy, Asthma, and Immunology. J Allergy Clin Immunol 1997; in press.
28. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T-cell and antibody responses to house dust mite allergen by inhalation of the dominant epitope in naive and sensitized mice. J Exp Med 1993;178: 1783-8.
29. Smith AM, Chapman MD. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen. Der p 2. Mol Immunol 1996;33:399-405.
30. Smith AM, Chapman MD. Localization of antigenic sites on Der p 2 using oligonucleotide directed mutagenesis targeted to predicted surface residues. Clin Exp Allergy 1997; in press.
31. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994;344: 456-8.
32. 1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Nat Acad Sci U S A 1996;93:5141-5.
33. Hsu C-H, Chua K-Y, Tao M-H, et al. Immunoprophylaxis of allergen induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 1996;2:540-4.
34. Norman PS, Ohman JL, Long AA, et al. Treatment of cat allergy with T cell reactive peptides. Am J Respir Crit Care Med 1996;154:1623-8.